Free Investor Fireside Webinar
Longevity is for the billions, not just the billionaires.
Democratizing access to longevity will be the key as the largest global medical sector in history accelerates. It’s set to be a $600bn market opportunity by 2025 (Bank of America), other analysts value the category even higher.
With so many complex factors driving this paradigm shift in healthcare, how can investors leverage this opportunity?
Cutting through hype, and the vast body of scientific and economic research, this webinar will unlock the secrets of the longevity investment space, and guide investors through the opportunities and risks.
By providing your cell phone number, you are providing express “written” consent for us to send text messages from Longr. I understand that this authorization overrides any previous registrations on a federal or state Do Not Call registry. Msg freq may vary. Msg & data rates may apply. We will never sell or share your information with third parties. To opt out reply STOP.
First movers have included OpenAI founder Sam Altman, Jeff Bezos and Peter Thiel. Now we are seeing access for everyone as the driver of a new generation of early longevity plays.
We welcome investors of all types to participate.
We follow a fireside chat format, encouraging questions, answers and debate. It’s an intimate way to dive deep.
What are the key ideas and takeaways?
How will longevity arrive for everyone?
What will be humanity's next big breakthrough?
longevity fundamentals
From an introduction to the world of longevity science and medicine, through an outline of the market, and into the granularity of longevity investing. The first half of the webinar will lay a solid foundation.
deeper longevity dives
Expanding access from the super rich to the general public, and bringing drugs to market faster and more cost effectively. The second half of the webinar looks at two critical areas driving future growth in the market.
Longr is a synergistic platform company building access to longevity, driven by AI and personalization.
Longr works across generative AI, ML, therapeutics, consumer wellness products, and clinics, operating with a Hub and Spoke model.
Combining the latest in AI-powered computational chemistry and longevity drug design, April 19 is developing a unique class of compounds.
These may provide a much-needed answer to the ever-rising threat of dementia and cognitive decline in our aging population.
Featured Speakers
20-years in VC and venture-building
100m app downloads
30 biotech investments
Over 10 exits / IPOs
Prof. of Computer Science at UCL
Deep tech expert
OBE
Serial entrepreneur
Times & Tickets
Time slots are available across all time zones and schedules.
We use cookies to enhance content, analyze web traffic, and assess other website performance metrics.